Moderator: Kimberly Ha

CEO and Founder, KKH Advisors | WAMJ Editorial Board Member

​

Kimberly Ha is the founder and CEO of KKH Advisors, a life sciences strategic communications advisory firm. She was previously Senior Director at FTI Consulting, Healthcare Capital Markets Communications, where she advised a broad range of clients from Fortune 500 to early-stage development companies on business transformation, corporate and executive positioning, crisis and issues management, and financial communications. She is a digital health advisor at UCSF Health Hub, Springboard Enterprises, and a Limited Partner at Array Ventures, a SF-based tech VC fund.

Edward Cox

EVP Strategic Alliances & Global Health of Digital Medicine | Eversana 

​

Eward is a respected a thought leader in the digital therapeutics sector, having built a foundation for the entire industry that allowed hundreds of companies to follow. He is uniquely positioned to lead digital medicine companies and initiatives in this rapidly expanding space: He has background in executive leadership across numerous industries including pharma and biotech, technology, investment banking, and public markets. He led Dthera Sciences as CEO from inception into a pioneering Digital Therapeutics company that was granted FDA Breakthrough Device designation for the treatment of Alzheimer’s disease and recognized as a top 10 company in the Digital Therapeutics sector. He has been asked to serve highly visible roles at the most prominent events in the digital medicine space including serving as chair at DTx Europe, and DTx West and East. He excels at finding creative and asymmetric pathways to drive success from business development to commercial launch. He adept at investor relations, corporate development and building high profile strategic partnerships.

Brian Harris 

CEO and Co-Founder, MedRhythms, Inc.

Brian is the CEO and co-founder of MedRhythms. He is passionate, motivated, and committed to bringing high-quality care to everyone who needs it. This vision inspired the creation of MedRhythms and has allowed the company to expand and evolve to better serve patients. In 2011, Brian completed his undergraduate degree in Psychology at the University of Maine and went on to receive his masters in Music Therapy. After completing his masters, Brian continued to expand his knowledge and experience in the field, ultimately becoming a Board-Certified Music Therapist with specialized training in Neurologic Music Therapy (NMT). He later received advanced training in the field, becoming one of only 350 people in the world with the distinction of NMT Fellow. Harris was hired as the first NMT at Spaulding Rehabilitation Hospital in Boston, where, in 2015, he founded the clinical division of MedRhythms focusing on stroke, brain injury, and neurologic disease. With his continued leadership, the therapy practice has grown into the most comprehensive NMT program in the country.

Eddie Martucci, PhD

CEO and Co-Founder, Akili Interactive

Eddie co-founded Akili Interactive, and as part of PureTech has co-founded two other health-focused start-ups, and helped launch their digital health initiative. He was previously a Kauffman Entrepreneur Fellow, a program sponsored by the Kauffman Foundation of Kansas City, MO, focused on healthcare entrepreneurship. Prior to that, he completed his graduate work at Yale University in the Departments of Pharmacology and Molecular Biophysics & Biochemistry, focusing on structure-based drug design, where he led a research project that identified two novel chemical scaffolds as proof-of-concept compounds for novel therapy. Eddie received his B.S. in Biochemistry from Providence College, and his M.Phil. and Ph.D. from Yale University. Eddie frequently serves on discussion panels for industry and academic events related to healthcare innovation, has appeared in media including CNN's Vital Signs with Sanjay Gupta, and Akili has received recognition including the 2014 Future of Health Technology product award, 2015 50-on-Fire Boston, and the #1 health company in Entrepreneur magazine's 100 Brilliant Companies of 2016.

Joseph McMenamin, MD, JD

EVP, W Medical Strategy Group

Joseph (Joe) P. McMenamin is an Executive Vice President and Chief Legal Officer with W Medical Strategy Group. He has more than 20 years of experience in defending pharmaceutical, medical device, and biotech companies in state and federal court. He also advises clients on managing risks related to telemedicine, corporate use of the internet, social media, communications between life science companies and physicians, compliance with FDA regulations.

Brent Vaughan

CEO, Cognito Therapeutics

Brent Vaughan is CEO of Cognito Therapeutics, a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders including Alzheimer’s disease. With more than 20 years of experience, he has a proven track record of success developing proprietary technologies and products across multiple domains, including digital therapeutics, medical devices and pharmaceuticals. Prior to Cognito, Brent was Chief Executive Officer and Co-Founder at Cognoa, an AI-based digital therapeutics company, where he established the company as a leader in digital therapeutics and pediatric behavioral health. Under his leadership, Cognoa was awarded FDA Breakthrough Designation for the first two products for autism and successfully completed the clinical development of the lead product. He was also co-founder at WellnessFX, a leading digital health company. Brent has also held leadership positions in business development and product management in therapeutic and medical device companies including Saegis Pharmaceuticals, Nektar Therapeutics, and Roche. He received his M.B.A. from Santa Clara University and a B.S. in Biochemistry from the University of California, Davis.